EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB

Shuhua Song iD, Qingxin Liu iD, Aoqi Luo, Xiao Shi iD, Xinxin Si iD

Chemical Biology & Drug Design · 2026-11 · 108 (5)

DOI: 10.1111/cbdd.70422 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-11-05. Written by Shuhua Song and 4 co-authors. Institution: School of Pharmacy, Jiangsu Ocean University, Lianyungang, China. Major MEDLINE topics: Machine Learning, Escherichia coli, Enzyme Inhibitors, Anti-Bacterial Agents. 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Jiangsu Ocean University.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

MurB, a key enzyme involved in bacterial cell wall biosynthesis, represents a promising target for antibacterial drug discovery. In this study, a machine learning assay was employed to identify potential inhibitors targeting E. coli MurB. Five machine learning models were constructed using AutoMolDesigner, of which the RDKit_2D ‐ based Model_2 was selected as the optimal activity ‐ prediction model for virtual screening of an in ‐ house compound library, yielding 238 compounds. These compounds were subsequently subjected to FRED molecular docking, and 16 candidate compounds were selected based on their hydrogen ‐ bond interactions with the key active ‐ site residue ASN A:233. Preliminary enzyme inhibition assays conducted at 50 μM identified 4 compounds (Q9, Q11, Q12, and Q13) with inhibition rates exceeding 50%. Further IC₅₀ determination revealed values of 34.44, 31.45, 25.08, and 25.94 μM, respectively. Molecular dynamics simulations combined with principal component analysis were performed to investigate the dynamic behaviors and binding stability of the MurB ‐ ligand complexes. In addition, a CCK ‐ 8 assay was conducted in HepG2 cells to evaluate the cytotoxicity of the active compounds preliminarily. Collectively, 4 low ‐ cytotoxic micromolar MurB inhibitors were identified in this study, offering promising scaffolds for further mechanistic investigation and structural optimization.

Subjects

MeSH terms (MEDLINE)

Machine LearningEscherichia coliEnzyme InhibitorsAnti-Bacterial AgentsMolecular Docking SimulationHumansMolecular Dynamics SimulationHep G2 CellsDrug DiscoveryHydrogen BondingCatalytic DomainPrincipal Component AnalysisAlkyl and Aryl Transferases

Author keywords

MurBmachine learningmolecular dockingvirtual screening

Substances

Enzyme InhibitorsUDP-N-acetylglucosamine 1-carboxyvinyltransferaseAnti-Bacterial AgentsAlkyl and Aryl Transferases

Authors and institutions

  • School of Pharmacy, Jiangsu Ocean University, Lianyungang, China.

ORCID profiles: Shuhua Song, Qingxin Liu, Xiao Shi, Xinxin Si

Funding

  • Jiangsu Ocean University

Cite

APA

Song, S., Liu, Q., Luo, A., Shi, X., & Si, X. (2026). Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB. Chemical Biology & Drug Design, 108(5). https://doi.org/10.1111/cbdd.70422

Vancouver

Song S, Liu Q, Luo A, Shi X, Si X. Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB. Chemical Biology & Drug Design. 2026;108(5). doi:10.1111/cbdd.70422

BibTeX
@article{Song2026,
  author = {Song, Shuhua and Liu, Qingxin and Luo, Aoqi and Shi, Xiao and Si, Xinxin},
  title = {Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {5},
  doi = {10.1111/cbdd.70422}
}
Start for free →